Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome-Reference-Cited by-同舟云学术

Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome

Published:2008-01-14 Issue:9 Volume:41 Page:779-784
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Minnema M C,van de Donk N W C J,Zweegman S,Hegenbart U,Schonland S,Raymakers R,Zijlmans J M J M,Kersten M J,Bos G M J,Lokhorst H M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705982.pdf

Reference18 articles.

1. Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 2003; 102: 3447–3454.

2. Lokhorst HM, Wu K, Verdonck LF, Laterveer LL, van de Donk NW, van Oers MH et al. The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma. Blood 2004; 103: 4362–4364.

3. Perez-Simon JA, Sureda A, Fernandez-Aviles F, Sampol A, Cabrera JR, Caballero D et al. Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients. Leukemia 2006; 20: 542–545.

4. Byrne JL, Fairbairn J, Davy B, Carter IG, Bessell EM, Russell NH . Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission. Bone Marrow Transplant 2003; 31: 157–161.

5. Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL et al. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma. Eur J Haematol 2005; 75: 376–383.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease;Annals of Medicine;2023-12-12

2. A prognostic model for patients with primary extramedullary multiple myeloma;Frontiers in Cell and Developmental Biology;2022-11-25

3. Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas;Clinical Lymphoma Myeloma and Leukemia;2022-08

4. Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance;Frontiers in Oncology;2022-07-07

5. Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease;Frontiers in Oncology;2022-07-01